Phibro Animal Health | PAHC - Gross Profit On Sales


Phibro Animal Health reported $133.5M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Align Technology USD 683.59M 44.39M Dec/2025
ANI Pharmaceuticals USD 124.18M 12.39M Dec/2025
Assertio Holdings USD 22.24M 970K Jun/2024
Aurora Cannabis CAD 46.62M 14.33M Dec/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Canopy Growth CAD 21.47M 434K Dec/2025
Corcept Therapeutics USD 199.58M 3.46M Dec/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Henry Schein USD 1.06B 37M Dec/2025
Idexx Laboratories USD 658.11M 25.24M Dec/2025
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Merck USD 13.42B 431M Sep/2025
Nektar Therapeutics USD 13.75M 650K Jun/2024
Pacira USD 142.25M 11.34M Dec/2025
Phibro Animal Health USD 133.5M 12.6M Dec/2025
Prestige Brands USD 157.37M 5.79M Dec/2025
Supernus Pharmaceuticals USD 164.04M 15.23M Dec/2025
Zoetis USD 1.64B 73M Dec/2025